is glp 1 bad for kidneys Renal effects of GLP-1 receptor agonists and tirzepatide in individuals with type 2 diabetes: seeds of a promising future | Endocrine GLP-1 receptor agonists' impact on
Description
GLP-1RAs used for the treatment of type 2 diabetes was gradually expanded to other diseases, such as obesity [42], non-alcoholic fatty liver disease [43], and Alzheimers disease [44]

In the UK, NICE recommends semaglutide only within specialist weight management services and for a time-limited period

38.Elmaleh-Sachs A, Schwartz JL, Bramante CT, Nicklas JM, Gudzune KA, Jay M

While newer medications are making waves in the T1D space, metformin seems relatively stable
Yet, the introduction of oral semaglutide, a modified form of semaglutide with the addition of a carrier sodium N-(8-[2-hydroxybenzoyl] amino) caprylate, may have provided a safe and effective way to reach systemic circulation while other molecules are in development

Healthcare providers are increasingly recommending oral alternatives for patients seeking improved treatment convenience
